<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="17562">Cytidine</z:chebi>-5'-diphosphocholine (<z:chebi fb="0" ids="16436,49086">CDP-choline</z:chebi>, Citicoline, Somazina) is in clinical use (intravenous administration) for <z:hpo ids='HP_0001297'>stroke</z:hpo> treatment in Europe and Japan, while USA phase III <z:hpo ids='HP_0001297'>stroke</z:hpo> clinical trials (oral administration) were disappointing </plain></SENT>
<SENT sid="1" pm="."><plain>Others showed that <z:chebi fb="0" ids="16436,49086">CDP-choline</z:chebi> liposomes significantly increased brain uptake over the free drug in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> models </plain></SENT>
<SENT sid="2" pm="."><plain>Liposomes were formulated as DPPC, DPPS, cholesterol, GM(1) <z:chebi fb="0" ids="28892">ganglioside</z:chebi>; 7/4/7/1.57 molar ratio or 35.8/20.4/35.8/8.0 mol% </plain></SENT>
<SENT sid="3" pm="."><plain>GM(1) <z:chebi fb="0" ids="28892">ganglioside</z:chebi> confers long-circulating properties to the liposomes by suppressing phagocytosis </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="16436,49086">CDP-choline</z:chebi> liposomes deliver the agent intact to the brain, circumventing the rate-limiting, <z:chebi fb="0" ids="17562">cytidine</z:chebi> <z:chebi fb="0" ids="15266,18036">triphosphate</z:chebi>:<z:chebi fb="0" ids="36700">phosphocholine</z:chebi> cytidylyltransferase in <z:chebi fb="0" ids="49183">phosphatidylcholine</z:chebi> synthesis </plain></SENT>
<SENT sid="5" pm="."><plain>Our data show that <z:chebi fb="0" ids="16436,49086">CDP-choline</z:chebi> liposomes significantly ( P &lt; 0.01) decreased <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> (by 62%) compared to the equivalent dose of free <z:chebi fb="0" ids="16436,49086">CDP-choline</z:chebi> (by 26%) after 1 h focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and 24 h reperfusion in spontaneously hypertensive rats </plain></SENT>
<SENT sid="6" pm="."><plain>Beneficial effects of <z:chebi fb="0" ids="16436,49086">CDP-choline</z:chebi> liposomes in <z:hpo ids='HP_0001297'>stroke</z:hpo> may derive from a synergistic effect between the <z:chebi fb="0" ids="16247">phospholipid</z:chebi> components of the liposomes and the encapsulated <z:chebi fb="0" ids="16436,49086">CDP-choline</z:chebi> </plain></SENT>
</text></document>